The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,330.00
Bid: 2,329.00
Ask: 2,330.00
Change: 46.00 (2.01%)
Spread: 1.00 (0.043%)
Open: 2,291.00
High: 2,337.00
Low: 2,284.00
Prev. Close: 2,284.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Jan 2024 07:00

RNS Number : 3498B
Halma PLC
30 January 2024
 

Halma plc ("Halma" or "Company")Directorate Change

 

Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Giles Kerr as an independent non-executive Director, with effect from 1 February 2024. Giles will also be a member of Halma's Audit, Remuneration and Nomination Committees.

 

Giles brings a wealth of experience gained across a variety of roles in life sciences, technology and industrial businesses. Giles has a particularly strong background in driving strategic business growth as well as extensive M&A experience. He is currently Chair of PayPoint plc and was Senior Independent Director & Audit Committee Chair at Abcam plc, until it was acquired by Danaher in December 2023.

 

His executive career included senior financial roles at Arthur Andersen (leading to his appointment as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at Oxford University Innovation. Since 2007, Giles has held a number of non-executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford Sciences Innovation plc, Arix Bioscience plc and Senior plc.

 

Roy Twite, non-executive Director, who has served for nine years on the Board, will step down as a Director on 7 June 2024.

 

Dame Louise Makin, Chair, commented:"I am delighted that Giles is joining the Halma Board. His extensive executive and non-executive experience, particularly in the life sciences and technology sectors, will bring valuable insights and perspectives to the Board.

 

I would like to thank Roy for his valuable contribution to Halma, and particularly the support that he has given to me and the Board to ensure an orderly transition and onboarding of recent executive and non-executive Directors"

 

There are no further details to be disclosed for Giles Kerr under Listing Rule 9.6.13R.

 

 

For further information, please contact:

Halma plcMarc Ronchetti, Group Chief ExecutiveSteve Gunning, Chief Financial Officer

Charles King, Head of Investor Relations

Clayton Hirst, Director of Corporate Affairs

+44 (0)1494 721 111

+44 (0)7776 685948

+44 (0)7834 796 013

MHPOliver Hughes/Rachel Farrington/Ollie Hoare

+44 (0)20 3128 8100

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGFMVGFGDZG
Date   Source Headline
28th Jul 20163:06 pmRNSDirector/PDMR Shareholding
21st Jul 20166:01 pmRNSResult of AGM
21st Jul 20167:00 amRNSAGM Trading Update
1st Jul 201612:58 pmRNSTotal Voting Rights
21st Jun 20162:38 pmRNSAnnual Financial Report
14th Jun 20167:00 amRNSFinal Results
1st Jun 20162:21 pmRNSTotal Voting Rights
31st May 20164:15 pmRNSNotice of Results
3rd May 20162:22 pmRNSTotal Voting Rights
8th Apr 20162:22 pmRNSDirector Declaration
1st Apr 20163:37 pmRNSTotal Voting Rights
1st Mar 20164:58 pmRNSTotal Voting Rights
25th Feb 20165:13 pmRNSHome Member State
16th Feb 20164:21 pmRNSDirector/PDMR Shareholding
11th Feb 20167:00 amRNSTrading Update
5th Feb 20167:00 amRNSAcquisition
1st Feb 201612:27 pmRNSTotal Voting Rights
19th Jan 20162:31 pmRNSPDMR Shareholding
4th Jan 20162:30 pmRNSTotal Voting Rights
17th Dec 20157:00 amRNSAcquisition of Visiometrics
1st Dec 20154:28 pmRNSTotal Voting Rights
18th Nov 20151:12 pmRNSDirectorate Change
18th Nov 20151:01 pmRNSDoc re. Half Yearly Report
17th Nov 20157:00 amRNSHalf Yearly Report
6th Nov 20154:26 pmRNSNotice of Half Year Results and Dividend
2nd Nov 201512:47 pmRNSTotal Voting Rights
6th Oct 20157:00 amRNSAcquisition
5th Oct 201511:03 amRNSDirector/PDMR Shareholding
1st Oct 20156:15 pmRNSTotal Voting Rights
17th Sep 201510:00 amRNSInvestor Event
1st Sep 20154:14 pmRNSHolding(s) in Company
1st Sep 20152:48 pmRNSTotal Voting Rights
26th Aug 201510:53 amRNSDirector/PDMR Shareholding
11th Aug 20155:11 pmRNSDirector/PDMR Shareholding - Replacement
11th Aug 20152:38 pmRNSDirector/PDMR Shareholding
3rd Aug 20151:26 pmRNSDirector/PDMR Shareholding
3rd Aug 201512:33 pmRNSTotal Voting Rights
24th Jul 201510:06 amRNSDirectorate Change
23rd Jul 20155:33 pmRNSResult of AGM
23rd Jul 20157:00 amRNSAGM Trading Update
3rd Jul 201510:46 amRNSBlocklisting Interim Review
1st Jul 20152:19 pmRNSTotal Voting Rights
30th Jun 20154:56 pmRNSDirector Declaration
23rd Jun 201510:49 amRNSAnnual Financial Report
11th Jun 20157:00 amRNSFinal Results
1st Jun 201510:49 amRNSTotal Voting Rights
26th May 201512:18 pmRNSNotice of Results
15th May 20159:00 amRNSDirectorate Change
1st May 201511:10 amRNSTotal Voting Rights
28th Apr 20152:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.